Inventor

LUNN WILLIAM H W

41 patents

⚠️ This page may combine multiple inventors who share the name “LUNN WILLIAM H W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUNN WILLIAM H W

LILLY CO ELI

Methods for treating a physiological disorder associated with β-amyloid peptide

Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y

Immunosuppressants

Non-peptide tachykinin receptor antagonists to treat allergy

Excitatory amino acid receptor antagonists

Heterocyclic neuropeptide Y receptor antagonists

Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y

Non-peptide tachykinin receptor antagonists to treat psycological disorder

Use of bengothiophenls to treat pain due to an excess of neuropeptide y

Naphthyl tachykinin receptor antagonists to treat physiological conditions

NMDA receptor selective antagonists

Thieno and furopyridinium-substituted cephalosporins

Thieno and furopyridinium-substituted cephalosporins

Cephalosporin antibiotics

Dioximino cephalosporin antibiotics

Dioximino cephalosporin antibiotics

Pyrazinium substituted cephalosporins

Cephalosporin quinolinium betaines

7-[α-(2,3-DIHYDRO-2-OXO-1H-benzimidazol-1-ylcarbonyl-amino)arylacetamido]cephalosporins

Pentavalent phosphorus amides of cephalosporins and separation process using same

Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y

Methods of treating depression by inhibiting physiological conditions associated with an excess of neuropeptide Y

Cephalosporin betaines

Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins

3&#39;-Substituted quinolinium cephalosporins

Isoquinolinium substituted cephalosporins

Oximino-substituted cephalosporin compounds

Oxazole and oxadiazole cephalosporins

Excitatory amino acid receptor antagonists

Isoquinolinyl compounds which are intermediates

Methods of inhibiting physiological conditions associated with an excess of bradykinin

7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins

7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins

7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins

Excitatory amino acid receptor antagonists

Methods of inhibiting the effects of amyloidogenic proteins

Naphthyl bradykinin receptor antagonists

7-(2-(Substituted cinnolinoyl)amino)acetamido)-1-oxa-beta-lactams

Cephalosporin compounds

7-[α-(Benzimidazol-2-ylcarbonylamino)-arylacetamido]ephalosporins

SHIONOGI & CO

Dihydrotriazinylthiooxacephalosporins

3'-Substituted quinolinium cephalosporins